Clinical Trials Browser

Phase 1/2 × sintilimab × 30 days × Clear all

NCT06530251 2026-03-04

A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular